Skip to content
Covis Pharma, the maker of Makena, is planning the withdrawal after a study failed to confirm the drug works
Source link
Tags: APO, Apollo Global Management, C&E Industry News Filter, Content Types, corporate, Corporate/Industrial News, Factiva Filters, government policy, healthcare, Healthcare/Life Sciences, industrial news, life sciences, new products, New Products/Services, Pharmaceuticals, product, Product/Service Approvals, products, Products/Services, regulation, Regulation/Government Policy, service approvals, services, SYND, WSJ-PRO-WSJ.com, wsjhealth
